Breast Cancer Screening, Mammography, and Other Modalities / James V. Fiorica
Material type:
Continuing resourceISSN: 1532-5520Subject(s): guidelines for breast cancer screening | mammograms | digital breast tomosynthesis | magnetic resonance imaging | breast ultrasonography | clinical breast examination
In:
Clinical Obstetrics and Gynecology -- 2016, v. 59, 4, p. 688–709Summary: Abstract: This article is an overview of the modalities available for breast cancer screening. The modalities discussed include digital mammography, digital breast tomosynthesis, breast ultrasonography, magnetic resonance imaging, and clinical breast examination. There is a review of pertinent randomized controlled trials, studies and meta-analyses which contributed to the evolution of screening guidelines.
Ultimately, 5 major medical organizations formulated the current screening guidelines in the United States. The lack of consensus in these guidelines represents an ongoing controversy about the optimal timing and method for breast cancer screening in
women. For mammography screening, the Breast Imaging Reporting and Data System lexicon is explained which corresponds with recommended clinical management. The presentation and discussion of the data in this article are designed to help the
clinician individualize breast cancer screening for each patient.
| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Artículo de revista
|
Revistas y artículos | Non-fiction | PP (Browse shelf(Opens below)) | Available | 5611 |
Browsing Revistas y artículos shelves, Collection: Non-fiction Close shelf browser (Hides shelf browser)
PDF en biblioteca
Bibliografía: p.707-709
Abstract: This article is an overview of the modalities available for breast cancer screening. The modalities discussed include digital mammography, digital breast tomosynthesis, breast ultrasonography, magnetic resonance imaging, and clinical breast examination. There is a review of pertinent randomized controlled trials, studies and meta-analyses which contributed to the evolution of screening guidelines.
Ultimately, 5 major medical organizations formulated the current screening guidelines in the United States. The lack of consensus in these guidelines represents an ongoing controversy about the optimal timing and method for breast cancer screening in
women. For mammography screening, the Breast Imaging Reporting and Data System lexicon is explained which corresponds with recommended clinical management. The presentation and discussion of the data in this article are designed to help the
clinician individualize breast cancer screening for each patient.
There are no comments on this title.